Martingale Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.12M	Buy	139,964 +30,645	+28%	+$732K	0.08%	250
2025 Q4	$2.92M	Buy	109,319 +8,991	+9%	+$215K	0.07%	241
2025 Q3	$2.14M	Buy	100,328 +31,048	+45%	+$734K	0.05%	298
2025 Q2	$1.49M	Buy	+69,280	New	+$1.29M	0.04%	373
2023 Q3	–	Sell	-10,368	Closed	-$248K	–	777
2023 Q2	$248K	Sell	10,368 -4	-0%	-$89	﹤0.01%	730
2023 Q1	$195K	Sell	10,372 -2	-0%	-$38	﹤0.01%	783
2022 Q4	$165K	Buy	+10,374	New	+$162K	﹤0.01%	802
2016 Q4	–	Sell	-6,900	Closed	-$220K	–	955
2016 Q3	$220K	Sell	6,900 -10,644	-61%	-$361K	﹤0.01%	916
2016 Q2	$570K	Sell	17,544 -808	-4%	-$27K	0.01%	647
2016 Q1	$514K	Buy	+18,352	New	+$400K	0.01%	646
2013 Q4	–	Sell	-7,500	Closed	-$207K	–	980
2013 Q3	$207K	Buy	+7,500	New	+$157K	0.01%	951